Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Remyelination”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Not applicableStudy completedNCT00937677
What this trial is testing

Effect of Tysabri in Patients With Relapsing-Remitting Multiple Sclerosis: A Follow-up Magnetization Transfer Imaging (MTI) Study

Who this might be right for
Multiple Sclerosis
University at Buffalo 85
Not applicableUnknownNCT01918501
What this trial is testing

Testing Mitochondria Activity and Blood Lipid Content of Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
Ziv Hospital 120
Post-approval studies (Phase 4)UnknownNCT05902429
What this trial is testing

Effects of Oral Cladribine on Remyelination and Inflammation in Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Pontificia Universidade Católica do Rio Grande do Sul 10
Not applicableLooking for participantsNCT06796504
What this trial is testing

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

Who this might be right for
Relapsing Remitting Multiple Sclerosis
SetPoint Medical Corporation 60
Not applicableUnknownNCT04042363
What this trial is testing

Effect of Transorbital Electrical STIMulation of Optic Nerve on Remyelination After an Acute Optic Neuritis

Who this might be right for
Multiple SclerosisOptic Neuritis
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 45
Post-approval studies (Phase 4)Study completedNCT01085318
What this trial is testing

Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial

Who this might be right for
Multiple Sclerosis
EMD Serono 38
Testing effectiveness (Phase 2)Ended earlyNCT03536559
What this trial is testing

Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple SclerosisOptic NeuropathyOptic; Neuritis, With Demyelination
Clene Nanomedicine 73
Not applicableStudy completedNCT05783934
What this trial is testing

Demyelination and Remyelination in Multiple Sclerosis (MS) Detected by Brain Amyloid PET-CT

Who this might be right for
Multiple Sclerosis
Istituti Clinici Scientifici Maugeri SpA 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06330077
What this trial is testing

Ifenprodil as a ReMyelinating repurpOsed Drug in Multiple Sclerosis

Who this might be right for
Multiple SclerosisRemitting Relapsing Multiple Sclerosis
Assistance Publique - Hôpitaux de Paris 60
Not applicableLooking for participantsNCT05177523
What this trial is testing

Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS)Relapsing-remitting Multiple Sclerosis (RRMS)Secondary-progressive Multiple Sclerosis (SPMS)+1 more
University Hospital, Basel, Switzerland 300
Early research (Phase 1)Study completedNCT01244139
What this trial is testing

Safety Study of BIIB033 in Subjects With Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple SclerosisMultiple Sclerosis
Biogen 47
Early research (Phase 1)Study completedNCT02521545
What this trial is testing

Single-Dose Study of a New Formulation of BIIB061

Who this might be right for
Multiple Sclerosis
Biogen 8
Testing effectiveness (Phase 2)Looking for participantsNCT04121468
What this trial is testing

A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS)
The Hospital for Sick Children 20
Testing effectiveness (Phase 2)Study completedNCT01772199
What this trial is testing

Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GlaxoSmithKline 131
Testing effectiveness (Phase 2)Ended earlyNCT03222973
What this trial is testing

Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
Biogen 263
Early research (Phase 1)Study completedNCT06683612
What this trial is testing

PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary FibrosisMultiple Sclerosis+6 more
Contineum Therapeutics 16
Not applicableLooking for participantsNCT05258396
What this trial is testing

Exploring Cortical Remyelination in Children With Multiple Sclerosis

Who this might be right for
Children With Multiple Sclerosis
Assistance Publique - Hôpitaux de Paris 40